4//SEC Filing
OrbiMed Capital GP V LLC 4
Accession 0000947871-19-000201
CIK 0001609550other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 9:30 PM ET
Size
10.7 KB
Accession
0000947871-19-000201
Insider Transaction Report
Form 4
OrbiMed Capital GP V LLC
Director
Transactions
- Sale
Common Stock, $0.001 par value
2019-03-07$55.01/sh−68,218$3,752,672→ 1,761,956 total(indirect: See Footnotes) - Sale
Common Stock, $0.001 par value
2019-03-08$57.75/sh−290,231$16,760,840→ 1,471,725 total(indirect: See Footnotes)
ORBIMED ADVISORS LLC
Director
Transactions
- Sale
Common Stock, $0.001 par value
2019-03-07$55.01/sh−68,218$3,752,672→ 1,761,956 total(indirect: See Footnotes) - Sale
Common Stock, $0.001 par value
2019-03-08$57.75/sh−290,231$16,760,840→ 1,471,725 total(indirect: See Footnotes)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock ("Shares") were sold in multiple transactions at prices ranging from $54.89 to $55.26 inclusive. Upon request, the Reporting Persons undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission (the "SEC") full information regarding the Shares purchased at each separate price within the range set forth in this footnote.
- [F2]These Shares were sold in a block order at a price of $57.75.
- [F3]These securities are held of record by OrbiMed Private Investments V, LP ("OPI V"). OrbiMed Capital GP V LLC ("GP V") is the sole general partner of OPI V, and OrbiMed Advisors LLC ("Advisors"), a registered adviser under the Investment Advisors Act of 1940, as amended, is the sole managing member of GP V. By virtue of such relationships, GP V and Advisors may be deemed to have voting and investment power with respect to the securities held by OPI V noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Advisors exercised this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the Shares held by OPI V.
- [F4]This report on Form 4 is jointly filed by GP V and Advisors. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated a representative, currently Chau Khuong, an employee of Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes.
Documents
Issuer
Inspire Medical Systems, Inc.
CIK 0001609550
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001615374
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 9:30 PM ET
- Size
- 10.7 KB